National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES

1966 No. 80

_________

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1965.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1965.

Dated this twenty-first day of April, 1966.

CASEY

Governor-General.

By His Excellency’s Command,

(Signed) A. G. Forbes

Minister of State for Health.

_______

Amendments of the National Health (Pharmaceutical Benefits) Regulations 

Commencement.

1. These Regulations shall come into operation on the first day of May, 1966.

First, Second, Third, Fourth and Fifth Schedules.

2.The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

FIRST SCHEDULE

Regulation 10.

Drugs and Medicinal Preparations in the British Pharmacopoeia that are not to be supplied as, or except as specially provided used in, pharmaceutical Benefits.

Acetomenaphthone.	Apomorphine Injection.
Acetomenaphthone Tablets.	Bacillus Calmette-Guérin Vaccine.
Acetrizoic Acid.	Bemegride.
Alcohol (95%).	Benzhexol Hydrochloride.
Dilute Alcohols.	Benztropine Methanesulphonate.
Dehydrated Alcohol.	Betamethasone.
Almond Oil.	Bisacodyl.
Amethocaine Hydrochloride.	Bisacodyl Suppositories.
Amodiaquine Hydrochloride.	Bisacodyl Tablets.
Amphetamine Sulphate.	Botulinum Antitoxin.
Amylobarbitone Sodium Tablets.	Busulphan.
Antazoline Hydrochloride.	Butobarbitone.
Antimony Potassium Tartrate.	Butylated Hydroxyanisole.
Antimony Potassium Tartrate Injection.	Butylated Hydroxytoluene.
Antimony Sodium Tartrate.	Calciferol Solution.
Antimony Sodium Tartrate Injection.	Calcium Cyclamate.
Apomorphine Hydrochloride.	Caramiphen Hydrochloride.

* Notified in the Commonwealth Gazette on 28 April, 1966.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; and 1965, Nos. 51, 151 and 152.

3989/66.—Price 25c (2s. 6d.)  9/14.4.1966

First Schedule—continued

Caramiphen Tablets.	Dimethisterone Tablets.
Caraway.	Diodone Injection.
Carbimazole.	Diphtheria and Pertussis Vaccine.
Carbon Dioxide.	Dipipanone Hydrochloride.
Carbromal Tablets.	Dipipanone Injection.
Cardamom Fruit.	Dodecyl Gallate.
Cascara.	Domiphen Bromide.
Catgut, Sterilised Surgical.	Edrophonium Chloride.
Cellulose, Oxidised.	Emetine and Bismuth Iodide.
Cetylpyridinium Chloride.	Emetine Hydrochloride.
Chloral Betaine.	Erythromycin.
Chlorambucil.	Ethinyloestradiol.
Chloroquine Phosphate.	Ethisterone.
Chloroquine Sulphate.	Ethopropazine Hydrochloride.
Chlorothiazide.	Ethotoin.
Chlorphenesin.	Ethyl Chloride.
Chlorpropamide.	Ethyl Oleate.
Chorionic Gonadotrophin.	Ethylenediamine Hydrate.
Chorionic Gonadotrophin Injection.	Eugenol.
Cinchocaine Hydrochloride.	Ferric Citrate (30Fe) Injection.
Cinnamon.	Fludrocortisone Acetate.
Citric Acid, Anhydrous.	Fluocinolone Acetonide.
Cochineal.	Fluoxymesterone.
Colchicine.	Gallamine Triethiodide.
Colchicum Corm.	Gallamine Injection.
Colchicum Liquid Extract.	Gelatin Sponge, Absorbable.
Coriander.	Gentian.
Corticotrophin.	Ginger.
Cresol and Soap Solution.	Glutethimide.
Cresol.	Gold (108Au) Injection.
Crotamiton.	Griseofulvin.
Cyanocobalamin.	Guanethidine Sulphate.
Cyanocobalamin (57Co).	Halothane.
Cyanocobalamin (58Co).	Helium.
Cyclamic Acid.	Heparin.
Cyclizine Tablets.	Hexamethonium Tartrate.
Cyclobarbitone Calcium.	Hexamethonium Tartrate Injection.
Cyclomethycaine Sulphate.	Hexylresorcinol.
Cyclopropane.	Histamine Acid Phosphate.
Dapsone.	Human Blood, Whole.
Deoxycortone Trimethylacetate.	Human Red Blood Corpuscles, Concentrated.
Dequalinium Acetate.	Human Fibrin Foam.
Dequalinium Chloride.	Human Fibrinogen.
Dexamethasone.	Human Gamma Globulin.
Dexamethasone Acetate.	Human Gamma Globulin Injection.
Dexamphetamine Sulphate.	Human Plasma, Dried.
Dextromethorphan Hydrobromide.	Human Serum, Dried.
Dextromethorphan Tablets.	Human Thrombin.
Diamorphine Hydrochloride.	Hydrallazine Hydrochloride.
Diamorphine Injection.	Hydrallazine Tablets.
Dibromopropamidine Isethionate.	Hydrocortisone Ointment.
Dichloralphenazone.	Hydrocortisone Acetate Ointment.
Dichloralphenazone Tablets.	Hydrocortisone Hydrogen Succinate.
Dichlorophen.	Hydroflumethiazide.
Dichlorphenamide.	Hydrogen Peroxide Solution, Strong.
Diethazine Hydrochloride.	Hydroxocobalamin.
Diethylcarbamazine Citrate.	Hydroxychloroquine Sulphate.
Digitoxin.	Hyoscyamus.
Diloxanide Furoate.	Imipramine Hydrochloride.
Dimenhydrinate.	Indigo Carmine.
Dimenhydrinate Injection.	Influenza Vaccine.
Dimenhydrinate Tablets.	Iodinated (131I) Human Serum Albumin Injection.
Dimercaprol.	Iodipamide Methylglucamine Injection.
Dimethisterone.	Iodised Oil Fluid Injection.

First Schedule—continued

Iodised Oil Viscous Injection.	Opium, Powdered.
Iopanoic Acid.	Orange Peel, Dried Bitter.
Iopanoic Acid Tablets.	Orange Peel, Fresh Bitter.
Iophendylate Injection.	Oxygen.
Ipecacuanha, Prepared.	Oxytetracycline Dihydrate.
Ipecacuanha and Opium Tablets.	Paramethadione.
Isoniazid.	Pempidine Tartrate.
Isopropyl Alcohol.	Pentamidine Isethionate.
Lead Acetate.	Pentamidine Injection.
Lead Monoxide.	Perphenazine.
Lemon Peel, Dried.	Perphenazine Tablets.
Levallorphan Injection.	Pethidine Tablets.
Levorphanol Tartrate.	Phanquone.
Lignocaine Hydrochloride.	Phanquone Tablets.
Lignocaine and Adrenaline Injection.	Phenelzine Sulphate.
Lignocaine Hydrochloride Injection.	Phenelzine Tablets.
Liothyronine Sodium.	Phenindamine Tartrate.
Lucanthone Hydrochloride.	Phenindione.
Lucanthone Tablets.	Phenolphthalein Tablets.
Magnesium Stearate.	Phenolsulphonphthalein.
Male Fern.	Phenoxybenzamine Hydrochloride.
Maleic Acid.	Phenoxymethylpenicillin.
Mannitol.	Phentolamine Hydrochloride.
Measles Vaccine (Inactivated).	Phentolamine Tablets.
Measles Vaccine (Live Attenuated).	Phentolamine Methanesulphonate.
Mecamylamine Hydrochloride.	Phentolamine Injection.
Melarsoprol.	Phytomenadione.
Menaphthono Sodium Bisulphite.	Phytomenadione Capsules.
Mepacrine Hydrochloride.	Phytomenadione Tablets.
Mephentermine Sulphate.	Picrotoxin.
Mephentermine Tablets.	Piperazine Citrate.
Meprobamate.	Piperocaine Hydrochloride.
Meprobamate Tablets.	Poldine Methylsulphate.
Mercaptopurine.	Poldine Tablets.
Mersalyl Acid.	Poliomyelitis Vaccine (Inactivated).
Methadone Hydrochloride.	Poliomyelitis Vaccine (Oral).
Methandienone.	Potassium Chloride Injection.
Methoin.	Potassium Perchlorate.
Methyl Hydroxybenzoate.	Prednisone.
Methylamphetamine Hydrochloride.	Prednisone Acetate.
Methyldopa.	Primaquine Phosphate.
Methylthiouracil.	Primidone.
Methylthiouracil Tablets.	Probenecid.
Methyprylone.	Procainamide Hydrochloride.
Methyprylone Tablets.	Procaine and Adrenaline Injection.
Metronidazole.	Prochlorperazine Maleate.
Nalorphine Hydrobromide.	Prochlorperazine Methanesulphonate.
Nandrolone Phenylpropionate.	Prochlorperazine Tablets.
Naphazoline Hydrochloride.	Procyclidine Hydrochloride.
Neostigmine Bromide.	Progesterone.
Nicotinic Acid.	Proguanil Hydrochloride.
Nikethamide.	Promazine Hydrochloride.
Nikethamide Injection.	Promazine Injection.
Nitrous Oxide.	Promazine Tablets.
Norethandrolone.	Promethazine Theoclate.
Norethandrolone Tablets.	Promethazine Theoclate Tablets.
Norethisterone.	Propyl Gallate.
Norethisterone Tablets.	Propyl Hydroxybenzoate.
Noscapine.	Propyliodone.
Novobiocin Calcium.	Propyliodone Injection.
Novobiocin Sodium.	Propyliodone Oily Injection.
Nux Vomica.	Propylthiouracil.
Octyl Gallate.	Pyridostigmine Bromide.
Oestradiol Benzoate.	Pyrimethamine.
Opium.	Quillaia.

First Schedule—continued

Rabies Antiserum.	Suramin Injection.
Rabies Vaccine.	Suxamethonium Chloride.
Senna Leaf.	Testosterone.
Sesame Oil.	Testosterone Phenylpropionate.
Soda Lime.	Testosterone Phenylpropionate Injection.
Sodium Acetrizoate Injection.	Testosterone Propionate.
Sodium Anoxynaphthonate.	Tetrachloroethylene.
Sodium Antimonylgluconate.	Tetrachloroethylene Capsules.
Sodium Antimonylgluconate Injection.	Thiambutosine.
Sodium Aurothiomalate.	Thiomersal.
Sodium Bicarbonate Compound Tablets.	Thiopentone Sodium.
Sodium Bicarbonate Injection.	Thiopentone Injection.
Sodium Calciumedetate.	Thioridazine Hydrochloride.
Sodium Chromate (51Cr) Solution.	Thyroid.
Sodium Cyclamate.	Thyroxine Sodium.
Sodium Diatrizoate.	Tolazoline Hydrochloride.
Sodium Diatrizoate Injection.	Tolbutamide.
Sodium Fluoride.	Trichloroethylene.
Sodium Fusidate Capsules.	Triclofos Sodium.
Sodium Iodide (181I) Injection.	Triclofos Tablets.
Sodium Iodide (101I) Solution.	Trifluoperazine Hydrochloride.
Sodium Lauryl Sulphate.	Tripelennamine Hydrochloride.
Sodium Phosphate (88P) Injection.	Tryparsamide.
Sodium Stibogluconate.	Tryparsamide Injection.
Sodium Stibogluconate Injection.	Tuberculin, Old.
Solapsone.	Tuberculin Purified Protein Derivative.
Solapsone Tablets.	Tubocurarine Chloride.
Spironolactone.	Tubocurarine Injection.
Staphylococcus Antitoxin.	Typhoid-Paratyphoid A and B and Cholera Vaccine.
Stibophen.	Typhoid-Paratyphoid A and B and Tetanus Vaccine.
Stibophen Injection.	Typhoid-Paratyphoid A, B, and C Vaccine
Stramonium.	Undecenoic Acid.
Sulphadimidine Sodium.	Vancomycin Hydrochloride.
Sulphamethizole.	Vancomycin Injection.
Sulphamethoxypyridazine.	Vinyl Ether.
Sulphapyridine.	Vitamin A Ester Concentrate.
Sulphasomidine.	Yellow Fever Vaccine.
Sulphasomidine Tablets.	Zinc Undecenoate.
Sulphobromophthalein Sodium.	Zinc Undecenoate Ointment.
Suramin

__________

SECOND SCHEDULE

Regulation 10 (3.).

Allowable Compounds (if any) of Certain Drugs or Medicinal Preparations

Pharmaceutical Benefits	Allowable Compounds (if any)
Acrylic Resin .............................................................	__
Aluminium Powder, B.P.C. ........................................	Aluminium Powder B.P.C. with Liquid Paraffin B.P. and Zinc Oxide Ointment B.P.
Aluminium Sodium Silicate........................................	Aluminium Sodium Silicate with Belladonna
Amphotericin B. ........................................................	Tetracycline with a buffering agent and Amphotericin B.
Aneurine Hydrochloride, B.P. .....................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Antazoline Sulphate....................................................	Antazoline Sulphate with Naphazoline Nitrate B.P.

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Ascorbic Acid, B.P..........................................................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Attapulgite.........................................................................................................	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Bacitracin, B.P..........................................................................................................		Polymyxin B Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Betamethasone Disodium Phosphate	—
Betamethasone Phosphate.........................................................................................................	—
Calciferol.........................................................................................................	—
Calcium Lactobionate.........................................................................................................	Thenalidine with Calcium Lactobionate
Carbachol, B.P..........................................................................................................	—
Carbinoxamine Maleate.........................................................................................................	—
Carbromal, B.P..........................................................................................................	Carbromal B.P., with Pentobarbitone Sodium B.P.
Chloramine, B.P.........................................................................................................	—
Chloramphenicol, B.P..........................................................................................................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
Chlorhexidine Gluconate .........................................................................................................	—
Chlorpheniramine Maleate, B.P.........................................................................................................	—
Chlorpromazine Hydrochloride, B.P.	—
Chlortetracycline Hydrochloride, B.P.	—
Clemizole Tannate.........................................................................................................	—
Cortisone Acetate, B.P..........................................................................................................	—
Cymogran.........................................................................................................	—
Cyproheptadine Hydrochloride.........................................................................................................	—
Cyclizine Hydrochloride, B.P.........................................................................................................	Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Demecarium Bromide.........................................................................................................	—
Demethylchlortetracycline Hydrochloride, B.P..........................................................................................................	—
Dexchlorpheniramine Maleate.........................................................................................................	—
Dextran.........................................................................................................	Dextran with Dextrose B.P.
Dextran in Normal Saline
Dicyclomine Hydrochloride, B.P.C..........................................................................................................	—
Dienoestrol, B.P..........................................................................................................	—
Digoxin, B.P..........................................................................................................	—
Dihydrostreptomycin Sulphate, B.P. 1958	Dihydrostreptomycin Sulphate B.P. 1958 with Attapulgite, Pectin and Hydrated Alumina Powder B.P.
Dihydrostreptomycin Sulphate B.P. 1958 with Kaolin, Pectin and Aluminium Hydroxide Gel
Dihydrotachysterol.........................................................................................................	—
Dimethicone .........................................................................................................	—
Diphenhydramine Hydrochloride, B.P.........................................................................................................	Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Diphenylpyraline Hydrochloride.........................................................................................................	—
Diphtheria Vaccine, B.P..........................................................................................................	Diphtheria and Tetanus Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Dyflos, B.P.C..........................................................................................................	—
Ecothiopate Iodide.........................................................................................................	—
Entsufon.........................................................................................................	Hexachlorophane B.P. with Entsufon
Ergometrine Maleate.........................................................................................................	Oxytocin with Ergometrine Maleate
Ergotamine Tartrate, B.P..........................................................................................................	Ergotamine Tartrate B.P. with Caffeine B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. 1959 and Diphenhydramine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Erythromycin Oral Suspensions and Syrups	—

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Erythromycin Paediatric Drops.................................................	—
Ethosuximide ..............................................................................	—
Ferric Hydroxide ........................................................................	—
Ferrous Aminoacetosulphate ...................................................	—
Ferrous Succinate........................................................................	—
Framycetin Sulphate...................................................................	—
Fusidic Acid (Diethanolamine Salt).........................................	—
Galactomin...................................................................................	—
Glucose Indicator........................................................................	—
Gramicidin....................................................................................	Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Hamamelis Dry Extract, B.P.C.................................................	Hamamelis Dry Extract B.P.C. with Zinc Oxide, B.P.
Hexachlorophane, B.P................................................................	Hexachlorophane B.P. with Entsufon
Hexachlorophane B.P. with Lissapol
Hexachlorophane B.P. in Soap Solution
Hydrocortisone, B.P....................................................................	—
Hydrocortisone Acetate, B.P.....................................................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Ipecacuanha, B.P.........................................................................	Phenolphthalein B.P. with Aloin B.P.C., Dry Extract of Belladonna B.P., Strychnine B.P.C. 1959 and Ipecacuanha B.P.
Isoprenaline Hydrochloride.......................................................	—
Kanamycin Sulphate, B.P.C......................................................	—
Levallorphan Tartrate, B.P........................................................	Levallorphan Tartrate B.P. with Pethidine Hydrochloride B.P.
Lissapol.........................................................................................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Hexachlorophane B.P. with Lissapol
Lofenalac.....................................................................................	—
Magnesium Chloride...................................................................	Ammonium Chloride B.P. with Sodium Chloride B.P., Potassium Chloride B.P. and Magnesium Chloride
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Mebhydrolin Napadisylate, B.P.C............................................	—
Meclozine Hydrochloride, B.P..................................................	Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Mepyramine Maleate, B.P.........................................................	—
Methacycline...............................................................................	—
Methdilazine Hydrochloride.....................................................	—
Methyl Glucamine......................................................................	Theophylline B.P. with Methyl Glucamine
Minafen ........................................................................................	—
Morphine Tartrate.......................................................................	Morphine Tartrate with Tacrine
Naphazoline Nitrate, B.P...........................................................	Naphazoline Nitrate B.P. with Antazoline Sulphate
Neomycin Sulphate, B.P............................................................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.

Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Neomycin Sulphate B.P. with Kaolin B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Neostigmine Methylsulphate, B.P............................................	—
Nicotinamide, B.P.......................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Nitrofurantoin, B.P......................................................................	—
Nortriptyline Hydrochloride......................................................	—
Nystatin, B.P................................................................................	Tetracycline with a buffering agent and Nystatin B.P.
Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P.
Oxytetracycline Hydrochloride, B.P........................................	Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Oxytetracycline Hydrochloride B.P. with a buffering agent and Nystatin B.P.

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Oxytocin ......................................................................................	Oxytocin with Ergometrine Maleate
Pancreatin Enzyme, U.S.N.F. XI..............................................	—
Papaveretum, B.P.C....................................................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Penicillin, Benethamine, B.P.C................................................	Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzathine, B.P........................................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Benzyl, B.P................................................................	Penicillin, Benzyl B.P. with Streptomycin Sulphate B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Phenoxymethyl (Benzathine, Calcium, Hydrabamine or Potassium Salt or Free Acid)	—
Penicillin, Potassium, B.P..........................................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Penicillin, Procaine, B.P.............................................................	Penicillin, Benzathine B.P. with Procaine Penicillin B.P. and Potassium Penicillin B.P.
Fortified Procaine Penicillin Injection B.P.
Penicillin, Benethamine B.P.C. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Penicillin, Benzyl B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Penicillin, Sodium, B.P..............................................................	Penicillin, Benethamine B.P. with Procaine Penicillin B.P. and Sodium Penicillin B.P.
Pentolinium Tartrate, B.P..........................................................	Pentolinium Tartrate B.P. with Ephedrine Hydrochloride B.P.
Pertussis Vaccine, B.P................................................................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Pethidine Hydrochloride, B.P....................................................	Pethidine Hydrochloride B.P. with Levallorphan Tartrate B.P.
Pethidine Hydrochloride B.P. with Scopolamine Hydrobromide B.P.
Phenethicillin Potassium...........................................................	—
Pheniramine Maleate.................................................................	—
Phenytoin......................................................................................	—
Pipenzolate Methobromide.......................................................	—
Pituitary (Posterior Lobe), Powdered, B.P.C..........................	—
Polymyxin B. Sulphate, B.P......................................................	Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.
Oxytetracycline Hydrochloride B.P. with Polymyxin B. Sulphate B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P. and Neomycin Sulphate B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Polymyxin B. Sulphate B.P. with Propylene Glycol and Acetic acid
Methylprednisolone, B.P............................................................	—
Prednisolone Sodium Hemisulphate.......................................	—
Prednisolone Sodium Phosphate, B.P.C.	—
Prednisolone Trimethylacetate, B.P.........................................	—
Promethazine Hydrochloride, B.P............................................	—
Riboflavine, B.P..........................................................................	Vitamin A with Aneurine Hydrochloride B.P. Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Senna Fruit, B.P...........................................................................	—

Second Schedule—continued

Pharmaceutical Benefits	Allowable Compounds (if any)
Silver Nitrate, Toughened, B.P.......................................................	—
Sobee...................................................................................................	—
Sodium Lactate.................................................................................	Sodium Lactate with Potassium Chloride B.P. and Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P., Magnesium Chloride and Sodium Chloride B.P.
Sodium Lactate with Sodium Chloride B.P. and Dextrose B.P.
Sodium Lactate with Sodium Chloride B.P.
Sodium Lactate with Potassium Chloride B.P. and Dextrose B.P.
Sodium Potassium Tartrate, B.P.C.	Compound Effervescent Powder, B.P.C.
Sodium Tauroglycocholate, B.P.C. 1954	Sodium Tauroglycocholate B.P.C. 1954 with Cascara Dry Extract B.P.
Spearmint Oil, B.P.C........................................................................	Lissapol with Spearmint Oil B.P.C. and Cetrimide B.P.
Strychnine, B.P.C. 1959..................................................................	Phenolphthalein with Aloin, Dry Extract of Belladonna, Strychnine B.P.C. 1959 and Ipecacuanha
Sulphacetamide, B.P.C.....................................................................	Sulphacetamide B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Sulphafurazole, B.P.......................................................................... .	—
Sulphamerazine, B.P. 1958.............................................................	Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphathiazole B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphacetamide B.P.C.
Sulphamerazine B.P. 1958 with Sulphadiazine B.P. and Sulphadimidine B.P.
Sulphaphenazole, B.P.C...................................................................	—
Sulphathiazole, B.P.C.......................................................................	Sulphathiazole B.P.C. with Sulphamerazine B.P. 1958 and Sulphadiazine B.P.
Surgical Cement ...............................................................................	—
Surgical Cement Solvent.................................................................	—
Tacrine................................................................................................	Morphine Sulphate B.P. with Tacrine
Morphine Tartrate with Tacrine
Tetanus Vaccine, B.P........................................................................	Diphtheria and Tetanus Vaccine B.P.
Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride, B.P....................................................	Tetracycline Hydrochloride B.P. with a buffering agent
Tetracycline........................................................................................	Tetracycline with a buffering agent and Amphotericin B.
Tetracycline with a buffering agent and Nystatin B.P.
Thenalidine.........................................................................................	Thenalidine with Calcium Lactobionate
Thenalidine Tartrate.........................................................................	Thenalidine Tartrate with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobromine, B.P.C.........................................................................	Theobromine B.P.C. with Phenobarbitone B.P.
Thioridazine.......................................................................................	—
Tragacanth (Gum Karaya)..............................................................	—
Trimeprazine Tartrate, B.P.C..........................................................	—
Triprolidine Hydrochloride, B.P.C.................................................	—
Vasopressin........................................................................................	—
Velactin...............................................................................................	—
Viomycin Pantothenate...................................................................	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viomycin Sulphate, B.P...................................................................	Viomycin Sulphate B.P. with Viomycin Pantothenate
Viprynium Embonate......................................................................	—
Vitamin A...........................................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Vitamin D...........................................................................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D

THIRD SCHEDULE

Regulation 11.

Drugs and Medicinal Preparations Additional to the Drugs and Medicinal Preparations in the British Pharmacopoeia

Acetazolamide Sodium.	Calamine Cream Oily, A.P.F.
Acetohexamide.	Calcium Aurothiomalate.
Acidified Golden Syrup, A.P.F. 1955.	Calcium Di-Oxytetracycline.
Acriflavine, B.P.C.	Calcium Gluconogalactogluconate.
Acrylic Resin.	Calcium Lactobionate.
Adrenaline Hydrochloride.	Calcium Phosphate, B.P.C.
Adrenaline Mucate.	Calumba, Concentrated Infusion, B.P. 1948.
Agar, B.P.C. 1954.	Calumba Tincture, B.P. 1948.
Alkavervir.	Capsicum Ointment, B.P.C.
Aloin, B.P.C.	Capsicum Tincture, B.P.C.
Almond Oil Volatile Bitter, B.P.C. 1959.	Carbamazepine.
Aloxidone.	Carbarsone, B.P.C.
Aluminium Acetate Solution, B.P.C.	Carbinoxamine Maleate.
Aluminium Hydroxide Mixture, A.P.F.	Cardamom Aromatic Tincture, B.P.C.
Aluminium Sodium Polyhydroxy Monocarbonate Hexitol Complex.	Catechu Tincture, B.P.C.
	Cephaloridine.
Aluminium Sodium Silicate.	Cetomacrogol Emulsifying Wax, B.P.C.
Aluminium Powder, B.P.C.	Cetyl Alcohol Compound.
Amaranth Solution, A.P.F.	Chloramine, B.P.C.
Amaranth Solution, Compound, A.P.F.	Chloramphenicol Palmitate, B.P.C.
Amaranth Solution, B.P.C.	Chloramphenicol Stearate.
Aminocaproic Acid.	Chloramphenicol Succinate.
Amitriptyline Hydrochloride.	Chlorazanil Hydrochloride.
Ammonia Aromatic Spirit, B.P.C.	Chlorhexidine Diacelate.
Ammonia Solution Strong, B.P.C.	Chlorhexidine Gluconate.
Ammonium Bicarbonate, B.P.C.	Chlorobenzol Disulphonamide.
Ammonium Bromide, B.P.C.	Chlorotrianisene, B.P.C.
Amphotericin B.	Chlorthalidone, B.P.C.
Angiotensin Amide.	Cholera El Tor Combined Vaccine.
Antazoline Methanesulphonate, B.P.C.	Choline Theophyllinate, B.P.C.
Antazoline Sulphate.	Cinnamon Spirit, B.P.C. 1949.
Attapulgite.	Cinnamon Water, Concentrated, B.P.C.
Aurothioglucose.	Clemizole Hydrochloride.
Azathioprine.	Clemizole Tannate.
Beclamide.	Cloipamide.
Beeswax, Yellow, B.P.C.	Clove, Concentrated Infusion, B.P.C. 1954.
Belladonna Suppository, B.P. 1948.	Coal Tar, B.P.C.
Benedict’s Solution, A.P.F.	Cochineal Tincture, B.P. 1948.
Benzalkonium Chloride.	Coconut Oil, B.P.C. 1949.
Benzoin, B.P.C.	Codeine, B.P.C. 1954.
Benzoinated Lard, B.P.C. 1954.	Copper Sulphate, B.P.C.
Benzoin Compound Tincture, B.P.C.	Creosote, B.P.C. 1959.
Benzoin Tincture, B.P.C.	Cudbear Tincture, A.P.F. 1947.
Benzylpenicillin in Oil.	Curd Soap, B.P.C.
Bephenium Hydroxynaphthoate, B.P.C.	Cyclopenthiazide.
Betamethasone Disodium Phosphate.	Cyclothiazide.
Betamethasone Phosphate.	Cycrimine Hydrochloride.
Bethanidine Sulphate.	Cymogran.
Biperiden Hydrochloride.	Cyproheptadine Hydrochloride.
Bismuth Subgallate, B.P.C.	Death Adder Antivenene.
Bretylium Tosylate.	Demecarium Bromide.
Brompheniramine.	Deoxycortone Glucoside.
Brown Snake Antivenene.	Desferrioxamine.
Buchu Concentrated Infusion, B.P.C. 1954.	Deslanoside.
Butabarbital Sodium.	Dexamethasone Sodium Phosphate.
Butyl Aminobenzoate, B.P. 1953	Dexchlorpheniramine Maleate.
Cade Oil, B.P.C.	Dextran.
Caffeine and Sodium Benzoate, B.P.C. 1954.	Dextriferron.
Caffeine Citrate, B.P.C. 1959.	Dicyclomine Hydrochloride, B.P.C.
Cajuput Spirit, B.P. 1948.	Digitalis Tincture, B.P.C. 1959

Third Schedule—continued

Dihydroergotamine Methanesulphonate.	Hyoscine Methobromide.
Dihydromorphinone Hydrochloride, B.P.C. 1949.	Hypophosphorous Acid, Dilute, B.P.C.
Dihydrostreptomycin Sulphate, B.P. 1958.	Idoxuridine.
Dihydrotachysterol.	Indomethacin.
Dimethicone, B.P.C.	Insulin Injection, specially purified.
Dimethindene Maleate.	Insulin Isophane Injection, specially purified.
Diphenylpyraline Hydrochloride.	Insulin Injection, Special P (Pig).
Dipyridamole.	Iodochlorhydroxyquinoline.
Disodium Stilboestrol Diphosphate.	Iodoform, B.P.C. 1954.
Dithiazanine Iodide.	Iron Aminoates.
Dyflos, B.P.C.	Iron Dextran.
Ecothiopate Iodide.	Iron Oxide Saccharated.
Entsufon.	Iron Sorbitol Complex.
Ephedrine, B.P.C.	Isoprenaline Hydrochloride.
Ergot, Liquid Extract, B.P. 1914.	Isopropamide Iodide.
Erythromycin Ethyl Succinate.	Isothipendyl Hydrochloride, B.P.C.
Erythromycin Glucoheptonate.	Kanamycin Sulphate, B.P.C.
Erythromycin Lactobionate.	Kitasamycin.
Erythromycin Stearate.	Lanatoside-C.
Ethacrynic Acid.	Lavender Spike Oil, B.P.C.
Ethanolamine, B.P.C.	Lemon Tincture, B.P. 1958.
Ethanolamine Oleate.	Lincomycin Hydrochloride.
Ether Nitrous Spirit, B.P.C. 1959.	Lipopancreatin.
Ethionamide.	Lissapol.
Ethoxzolamide.	Lobelia Ethereal Tincture, B.P.C.
Ethylidene Dicoumarin.	Lofenalac.
Ethylnoradrenaline Hydrochloride.	Lypressin.
Ethyloestrenol.	Magenta, B.P.C.
Eucalyptol, B.P.C.	Magnesium Chloride.
Extract of Ox Bile, B.P. 1948.	Magnesium Hydroxide, B.P.C.
Ferric Hydroxide.	Mebhydrolin Napadisylate, B.P.C.
Ferrous Aminoacetosulphate.	Medroxyprogesterone Acetate.
Ferrous Carbonate Saccharated, B.P.C. 1959.	Melphalan.
Ferrous Phosphate Compound Syrup, B.P.C.	Mepenzolate Bromide.
Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.	Mercaptomerin Sodium.
Ferrous Succinate.	Mercuric Chloride, B.P.C.
Fluorouracil Sodium.	Mestanolone.
Folinic Acid.	Metaraminol Bitartrate.
Framycetin Sulphate.	Metformin Hydrochloride.
Frusemide.	Methacycline.
Fusidic Acid, Diethanolamine Salt.	Methazolamide.
Galactomin.	Methdilazine Hydrochloride.
Gall and Opium Ointment, B.P.C.	Methenamine Mandelale.
Gelsemium Tincture, B.P.C.	Methenolone Acetate.
Glucagon Hydrochloride.	Methotrexate.
Glucose Indicator.	Methoxamine Hydrochloride, B.P.C.
Glycerophosphate Compound Syrup, A.P.F.	Methsuximide.
Glycopyrronium Bromide.	Methyclothiazide.
Goats Milk, dehydrated.	Methyl Glucamine.
Gramicidin.	Methylphenobarbitone, B.P.C.
Hamamelis Dry Extract, B.P.C.	Methylprednisolone Acetate.
Hamamelis Liquid Extract, B.P.C.	Metyrapone.
Heparin Retard.	Minafen.
Hexocyclium Methylsulphate.	Morphine Tartrate.
Honey, Purified, B.P.C.	Myrrh Gum, Powdered, B.P.C.
Hydrargaphen.	Myrrh Tincture, B.P.C.
Hydrocyanic Acid, Dilute, B.P.C. 1954.	Nalidixic Acid.
Hydroxybenzoate Compound Powder, A.P.F.	Nandrolone Decanoate.
Hydroxyprogesterone Caproate.	Natamycin.
Niclosamide.
Nicotinyl Alcohol Tartrate.
Nicoumalone.
Nitromin.
Nortriptyline Hydrochloride.

Third Schedule—continued

Nux Vomica, Dry Extract, B.P.C.	Quillaia Tincture, B.P.C.
Oestradiol Dipropionate, B.P.C. 1954.	Quinethazone.
Oestrone, B.P.C. 1954.	Raspberry Syrup, B.P.C.
Oily Ophthalmic Vehicle, A.P.F. 1955.	Rauwolfia Alkaloids.
Orange Peel Compound, Concentrated Infusion, B.P.C. 1954.	Red Back Spider Antivenene.
Orange Peel, Concentrated Infusion, B.P.C.	Rolitetracycline.
Orciprenaline Sulphate.	Rosemary Oil, B.P.C.
Oxycodone Pectinate.	Salicylamide.
Oxymel, B.P.C.	Senega, Concentrated Infusion, B.P.C.
Oxymel of Squill, B.P.C.	Senna Compound Mixture, B.P.C. 1959.
Oxymesterone.	Senna, Concentrated Infusion, B.P.C. 1959.
Oxyphencyclimine Hydrochloride.	Senna Fruit Extract (Standardised).
Oxyphenonium Bromide.	Siberian Fir Oil, B.P.C. 1949.
Oxytetracycline.	Silver Protein, B.P.C.
Oxytocin.	Silver Protein Mild, B.P.C.
Pancreatin Enzyme, U.S.N.F. XI.	Sobee.
Papaveretum, B.P.C.	Sodium Carbonate Anhydrous, B.P.C.
Para-Aminosalicylic Acid.	Sodium Edetate, B.P.C.
Paraben Ophthalmic Phosphate Buffer, A.P.F. 1955.	Sodium Folate.
Paraben Ophthalmic Vehicle, A.P.F. 1955.	Sodium Lactate.
Paraffin Liquid Light, B.P.C.	Sodium Nitrite, B.P.C.
Paramethasone Acetate.	Sodium Potassium Tartrate, B.P.C.
Pargyline Hydrochloride.	Sodium Tauroglycocholate, B.P.C., 1954.
Pectin.	Spearmint Oil, B.P.C.
d-Penicillamine Hydrochloride, B.P.C.	Spiramycin.
Penicillinase.	Squill Tincture, B.P.C.
Penicillin, Benethamine, B.P.C.	Stanolone.
Pentaerythritol Tetranitrate, diluted, B.P.C.	Stanozolol.
Penthienate Methobromide.	Stearic Acid, B.P.C.
Pertussis Vaccine (Haemagglutinin Aluminium Phosphate Adsorbed).	Storax, Prepared, B.P.C.
Peru Balsam, B.P.C.	Strophanthus Tincture, B.P. 1948.
Phenazone, B.P.C.	Strychnine, B.P.C. 1959.
Phenazopyridine Hydrochloride.	Sulphacetamide, B.P.C.
Phenethicillin Potassium.	Sulphadiazine Sodium, B.P.C.
Phenformin Hydrochloride.	Sulphadimethoxine, B.P.C.
Pheniramine Maleate.	Sulphaguanidine, B.P.C.
Pheniramine Para-Aminosalicylate.	Sulphamerazine, B.P. 1958.
Phenol Ointment, B.P. 1948.	Sulphamethoxydiazine.
Phenoxymethylpenicillin, Benzathine.	Sulphaphenazole, B.P.C.
Phenoxymethylpenicillin, Hydrabamine.	Sulphasalazine.
Phensuximide.	Sulphathiazole, B.P.C.
Phenthimentonium.	Sulphinpyrazone, B.P.C.
Phenytoin.	Sulphomyxin Sodium.
Phthalylsulphacetamide.	Sulphurated Potash, B.P.C.
Physostigmine, B.P.C.	Sulphuric Acid, Dilute, B.P.C.
Pipenzolate Methobromide.	Sulphur Sublimed, B.P.C.
Pituitary (Posterior Lobe) Powdered, B.P.C.	Sultiame.
Polythiazide.	Surgical Cement.
Potable Water.	Surgical Cement Solvent.
Potassium Chlorate, B.P.C.	Sustanon.
Potassium, Effervescent Tablets.	Syrup Glucose Liquid, B.P.C.
Prednisolone Sodium Hemisuccinate.	Tacrine.
Prednisolone Sodium Hemisulphate.	Taipan Antivenene.
Prednisolone Sodium Phosphate, B.P.C.	Tar Ointment, B.P.C. 1959.
Prednisolone Tertiary Butyl Acetate.	Tartrazine, B.P.C. 1954.
Protoveratrines A.	Testosterone Oenanthate.
Pumilio Pine Oil, B.P.C.	Tetanus Immune Globulin (Human).
Pyrazinamide.	Tetracycline.
Pyridine Aldoxime Methiodide.	Thenalidine.
Thenalidine Tartrate.
Theobromine, B.P.C.
Theobromine and Sodium Salicylate, B.P. 1953.
Theophylline Ethanoate of Piperazine.

Third Schedule—continued

Thiethylperazine.	Trimustine Hydrochloride.
Thioridazine.	Trinitrophenol, B.P.C. 1959.
Thiotepa.	Triprolidine Hydrochloride, B.P.C.
Thyrotrophin.	Trolnitrate Phosphate.
Tiger Snake Antivenene.	Vadrine.
Titanium Dioxide, B.P.C.	Valerian Ammoniated Tincture, B.P.C.
Tolu Tincture, B.P.C. 1959.	Vanillin.
Tragacanth (Gum Karaya).	Vasopressin Tannate.
Trasylol.	Velactin.
Tretamine.	Vinblastine Sulphate.
Triamcinolone, B.P.C.	Vincristine Sulphate.
Triamterene.	Vinegar of Squill, B.P.C.
Tricyclamol Chloride.	Viomycin Pantothenate.
Tridihexethyl Chloride.	Viprynium Embonate.
Triethanolamine, B.P.C.	Vitamin A.
Trimeprazine Tartrate, B.P.C.	Vitamin D.

___________________

 

FOURTH SCHEDULE

Regulation 12.

 

Additives
Acetone, B.P.C. B.P.C.	Caraway Oil, B.P.C.
Alcohol (95%), B.P.	Carmine Solution, A.P.F.
Dilute Alcohols, B.P.	Citronella Oil, B.P.C.
Amethocaine Hydrochloride, B.P.	Xylene, B.P.C. 1949.

________________

FIFTH SCHEDULE

Regulation 14.

Pharmaceutical Benefits the Prescribing of Which is Subject to Conditions and Restrictions

 

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Acetylsalicylic Acid Tablets, B.P....................................................
Soluble Acetylsalicylic Acid Tablets B.P......................................
Compound Acetylsalicylic Acid Tablets, A.P.F............................ .	Any disease or condition in a pensioner
Compound Acetylsalicylic Acid Tablets, B.P.C...........................
Soluble Compound Acetylsalicylic Acid Tablets........................
Acrylic Resin .....................................................................................	Ileostomy or colostomy conditions
Alkavervir ...........................................................................................	Hypertensive crises
Aminocaproic Acid ...........................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Amitriptyline Hydrochloride ...........................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Amphotericin B..................................................................................	Systemic fungal infection
Ampicillin Capsules, B.P..................................................................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Ampicillin is the only appropriate antibiotic
Ampicillin Injections.........................................................................
Ampicillin Tablets.............................................................................
Aneurine Hydrochloride Tablets, B.P.............................................	Any disease or condition in a pensioner
Angiotensin Amide............................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ascorbic Acid Tablets, B.P..............................................................	Any disease or condition in a pensioner
Azathioprine........................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Beclamide
Bemegride Injection, B.P..................................................................	As an antidote to barbiturate and other hypnotic poisons
Betamethasone Tablets.....................................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Betamethasone Disodium Phosphate Injection	Intra-articular use
Bethanidine Sulphate........................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Busulphan Tablets, B.P.....................................................................	Leukaemia
Any disease or condition in a pensioner
Calciferol Tablets, B.P......................................................................	With the written authority of the Director-General—
Calciferol, B.P.....................................................................................	Hypoparathyroidism
Chronic hypoparathyroid tetany
Vitamin D-resistant rickets
Calcium Aminosalicylate.................................................................	Tuberculosis
Calcium Gluconogalactogluconate Effervescent Tablets...........	Hypoparathyroidism
Carbamazepine..................................................................................	Epilepsy
Trigeminal neuralgia
Cephaloridine......................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Chlorambucil Tablets, B.P................................................................	Malignant lymphoma and related conditions
Chloramine Deodorant Tablets and Powder..................................	Ileostomy or colostomy conditions
Chloramphenicol Capsules, B.P......................................................	Bacterial meningitis
Haemophilus influenzae infections
Intra-ocular infections
Rickettsial infections
Salmonella septicaemia
Typhoid and paratyphoid
Other serious infections sensitive only to Chloramphenicol
Chloramphenicol Injections.............................................................	A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol Tablets .................................................................
Chloramphenicol Oral Suspension
Chlorotrianisene Tablets...................................................................	Carcinoma of the prostate
Chlorpromazine Hydrochloride.......................................................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Chlorpromazine Hydrochloride—continued	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride, or Nortriptyline Hydrochloride
Chlortetracycline Capsules, B.P......................................................	Brucellosis
Herpes zoster ophthalmicus
Intestinal amoebiasis
Leptospirosis
Lymphogranuloma venereum
Psittacosis
Rickettsial infections
Any bacterial infections or actinomycosis or trachoma where these cannot be treated safely and effectively by sulphonamides or penicillins
Pre-operative and post-operative therapy where there are reasonable grounds for believing that infection may occur
Chlortetracycline Hydrochloride Granules	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Choline Theophyllinate....................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cloxacillin Sodium, B.P.................................................................... .
Cloxacillin Capsules, B.P.................................................................
Compound Codeine Tablets, B.P.
Compound Codeine Soluble Tablets, B.P
Codeine Phosphate with Acetylsalicylic Acid Soluble Tablets
Codeine Phosphate with Acetylsalicylic Acid Tablets	Any disease or condition in a pensioner
Codeine Phosphate with Acetylsalicylic Acid and Phenacetin Tablets
Codeine Phosphate with Acetylsalicylic Acid, Phenacetin and Caffeine Tablets.................................................................................
Cod Liver Oil Emulsion....................................................................	Any disease or condition in a child under the age of twelve years or in a pensioner
With the written authority of the Director-General—
Corticotrophin Injection, B.P...........................................................	A disease or condition specified in this column in relation to Cortisone Injection
Corticotrophin Gelatin Injection, B.P.	Hypsarrhythmia
Corticotrophin Zinc Hydroxide Injection, B.P.	Salaam convulsions
	The prevention of side effects of corticosteroid therapy
Cortisone Injection, B.P....................................................................	With the written authority of the Director-General—
Anaemia, acquired haemolytic
Addison’s disease
Adrenocortical hypoplasia
Adrenalectomy, total
Adrenogenital syndrome

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Cortisone Injection, B.P.—continued	With the written authority of the Director-General—continued
Agranulocytosis
Behcet’s syndrome
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative
Dermatomyositis
Encephalomyelitis
Encephalomyelitis, acute disseminated
Guillain-Barré syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Keratoplasty
Leucine-sensitive hypoglycaemia
Leukaemia
Lymphosarcoma and follicular lymphoma
Metastatic breast cancer
Mycosis fungoides
Nephrosis or nephrotic syndrome
Neuromyelitis optica
Optic neuritis following removal of tumor of the brain
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Progressive transverse myelitis
Pseudohermaphroditism
Purpura, Henoch’s
Purpura, thrombocytopenic
Regional ileitis (Crohn’s disease)
Recticulum cell sarcoma
Rheumatic carditis, acute
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropenia
Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in a child under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Tropical and non-tropical sprue and all forms of malabsorption associated with those diseases
Type II Nephritis
Ulcerative colitis proven by sigmoidoscopy or radiological report
Cortisone Tablets, B.P...................................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Established megalocytic anaemia
Cyanocobalamin Injection, B.P.......................................................	Neuroblastoma
Subacute combined degeneration of the cord
Cymogran............................................................................................	With the written authority of the Director-General, phenylketonuria
Cycloserine, B.P.................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Cycloserine Capsules, B.P................................................................
Dapsone Tablets, B.P.........................................................................	Hansen’s disease
Demethylchlortetracycline Capsules, B.P.	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
Demethylchlortetracycline Hydrochloride Oral Paediatric Drops and Oral Suspension
Deodorant Detergent Solution (Lissapol with Spearmint Oil and Cetrimide)	Ileostomy or colostomy conditions
Deoxycortone Aqueous Injections
Deoxycortone Acetate Injection, B.P.	Addison’s disease
Deoxycortone Trimethylacetate Injection, B.P.	Adrenalectomy, total
Deoxycortone Acetate Implants, B.P.
Deoxycortone Acetate Tablets.........................................................
Desferrioxamine.................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dexamethasone Tablets, B.P............................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Dexamethasone Sodium Phosphate Injections	Intra-articular use
Dienoestrol Cream.............................................................................	Any disease or condition in a pensioner
Dienoestrol Tablets, B.P...................................................................	Carcinoma of the prostate
Mammary carcinoma
Any disease or condition in a pensioner
Dihydrostreptomycin Sulphate Injection	As an alternative to Streptomycin Sulphate in the case of a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Dihydrotachysterol............................................................................	Parathyroid deficiency
Diiodohydroxyquinoline Vaginal Tablet	Trichomonal or monilial vaginitis
Diiodohydroxyquinoline Effervescent Gynaecological Pessary
Diloxanide Furoate Tablets, B.P......................................................	Amoebic dysentery
Dimethicone........................................................................................	Ileostomy or colostomy conditions
Disodium Stilboestrol Diphosphate................................................	Carcinoma of the prostate
Dithiazanine Iodide...........................................................................	Infestations of Trichuris trichiura or Strongyloides stercoralis
Ditophal...............................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Erythromycin......................................................................................	Staphylococcal septicaemia or pneumonia
Any gram-positive bacterial infections where these cannot be treated safely and effectively by sulphonamides or penicillins
Ethacrynic Acid..................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ethinyloestradiol Tablets, B.P..........................................................	Turner’s syndrome
Pre-menopausal castration syndrome
Any disease or condition in a pensioner
Ethionamide........................................................................................	Tuberculosis

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Ethisterone Tablets, B.P....................................................................	Turner’s syndrome
Ethyloestrenol.....................................................................................	With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis
Fludrocortisone Tablets, B.P............................................................	Addison’s disease
Adrenocortical hypoplasia
Fluorouracil Sodium..........................................................................	Carcinoma of the colon and rectum
Fluoxymesterone Tablets, B.P.........................................................	Castration syndrome (male and female)
Mammary carcinoma
With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis
Folic Acid Injection...........................................................................	Macrocytic anaemia
Folic Acid Tablets, B.P.....................................................................	Sprue or the sprue-like syndrome
Folinic Acid.........................................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Framycetin Sulphate Tablets............................................................	Bowel sterilization preparatory to major surgery
Fusidic Acid (Sodium Salt or Diethanolamine Salt)	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Fusidic Acid (Sodium Salt or Diethanolamine Salt) is the only appropriate antibiotic
Galactomin..........................................................................................	With the written authority of the Director-General, galactosaemia
Goats Milk, dehydrated....................................................................	With the written authority of the Director-General, cows milk allergy in children under the age of four years
Griseofulvin Tablets, B.P..................................................................	With the written authority of the Director-General, for use in severe tinea infections due to Microsporum, Trichophyton or Epidermophyton species which have been proven by laboratory examination
Halibut Liver Oil Capsules ..............................................................	Any disease or condition in a pensioner
Hexachlorophane with Entsufon.....................................................

Any disease or condition in a patient receiving treatment in or at an approved hospital
	Hexachlorophane with Lissapol......................................................
	Hexachlorophane in Soap Solution
Hydrocortisone Injection..................................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Acetate Injection, B.P.	Intra-articular use
Hydrocortisone Sodium Succinate Injection	Acute adrenal failure due to medical or surgical crises
Stevens-Johnson syndrome
Hydrocortisone Sodium Succinate Soluble Tablet	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Established megalocytic anaemia
Hydroxocobalamin Injection, B.P...................................................	Neuroblastoma
Sub-acute combined degeneration of the cord
Hydroxyprogesterone Caproate .....................................................	Habitual abortion
Progesterone deficiency proven by hormonal assay of lateral wall smear
Idoxuridine..........................................................................................	Infections caused by Herpes Simplex Virus
Imipramine Tablets, B.P...................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be proscribed) for supply under Part VII. of the Act
Imipramine Tablets, B.P.—continued	The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Isoniazid Tablets, B.P...................................	Tuberculosis
Kanamycin Sulphate....................................	With the written authority of the Director-General, infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the only appropriate antibiotic
Kitasamycin...................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Levorphanol Tartrate....................................	Obstetrical use
Severe intractable pain
Lincomycin Hydrochloride..........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Liothyronine Tablets, B.P............................	Myxoedema
Myxoedema coma
Lipopancreatin..............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Lofenalac........................................................	With the written authority of the Director-General, phenylketonuria
Medroxyprogesterone Acetate Tablets	Endometrial carcinoma
Medroxyprogesterone Acetate Injections	Endometrial carcinoma
	Habitual abortion
Progesterone deficiency proven by hormonal assay of lateral wall smear
Melphalan......................................................	Malignant melanoma
Multiple myeloma
Mercaptopurine Tablets, B.P.......................	Allergic angiitis
Leukaemia
Lupus erythematosus
Periarteritis
Mestanolone...................................................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis
Methacycline..................................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules, except herpes zoster ophthalmicus
Methandienone Tablets, B.P........................	With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis
Methenolone Acetate....................................
Methicillin Sodium.......................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin Injection, B.P.............................
Methotrexate Tablets...................................	Leukaemia and neoplastic disease
Methotrexate Injections...............................	Any disease or condition in a patient receiving treatment in or at an approved hospital.
Metyrapone....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Minafen..........................................................	With the written authority of the Director-General, phenylketonuria
Morphine Sulphate, B.P. with Tacrine Tablets	Severe intractable pain
Mustine Hydrochloride Injection...............	Malignant lymphoma and related conditions

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Nalidixic Acid.........................................................................	With the written authority of the Director-General’ urinary tract infections where positive bacteriological evidence confirms that Nalidixic Acid is the only appropriate drug
Nandrolone Phenylpropionate Injection, B.P.	With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis
Nandrolone Decanoate.........................................................................
Natamycin.........................................................................	Monilial infections
Neomycin Tablets, B.P.........................................................................	Bowel sterilization preparatory to major surgery
Nicotinic Acid Tablets, B.P.........................................................................	Any disease or condition in a pensioner
Nitrofurantoin Tablets, B.P.........................................................................	Urinary tract infections
Nitrofurantoin Oral Suspension.........................................................................
Nitromin.........................................................................	Malignant lymphoma and related conditions
Nortriptyline Hydrochloride.........................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital.
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Nystatin Vaginal Tablets....................................................................	Proven monilia infections
Nystatin Tablets, B.P....................................................................
Orciprenaline Sulphate Injection....................................................................
Orciprenaline Sulphate Solution for Inhalation .. ..	Any disease or condition in a patient receiving treatment in or at an approved hospital
Oxycodone Pectinate....................................................................	Late-stage malignancy
Oxymesterone....................................................................	With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis
Oxytetracycline Hydrochloride Capsules
Oxytetracycline Tablets, B.P....................................................................	A disease or condition specified in this column in reflation to chlortetracycline Capsules except herpes zoster ophthalmicus
Oxytetracycline Injections
Calcium di-Oxytetracycline Oral Suspension
Calcium di-Oxytetracycline Paediatric Drops
Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
Oxytetracycline Hydrochloride with a buffering agent and Nystatin....................................................................	A second or repeated course of broad spectrum antibiotic therapy  for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Pancreatin, B.P....................................................................	Fibrocystic disease
Pancreatin Enzyme U.S.N.F. XI....................................................................	Pancreatico-duodenectomy
Pancreatic steatorrheoa
Para-Aminosalicylic Acid....................................................................	Tuberculosis

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Paracetamol Suspension....................................................................	Any disease or condition in a pensioner
Paracetamol Tablets, B.P....................................................................
Paramethasone Acetate....................................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion....................................................................	Any disease or condition in a pensioner
Paraffin Liquid Emulsion with Phenolphthalein .. ..
Pargyline Hydrochloride....................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Penicillamine....................................................................	With the written authority of the Director-General, Wilson’s disease (hepatolenticular degeneration)
Cystinuria with multiple renal calculi
Pethidine Hydrochloride with Levallorphan Tartrate	Obstetrical use
Benzylpenicillin with Streptomycin Sulphate	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Benzylpenicillin with Procaine Penicillin and Streptomycin Sulphate
Phenacetin with Codeine Phosphate and Pentobarbitone Sodium	Any disease or condition in a pensioner
Phytomenadione Injection, B.P....................................................................	Antidote to anticoagulants
Pituitary, Posterior Lobe, Insufflation	Diabetes insipidus
Polymyxin B. Sulphate Injection....................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisolone Sodium Phosphate Retention Enema....................................................................	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Prednisolone Tablets, B.P....................................................................	With the written authority of the Director-General—
Nodular non-suppurative panniculitis (Christian-Weber disease)
A disease or condition specified in this column in relation to Cortisone Injection except total adrenalectomy, Addison’s disease or adrenocortical hypoplasia
Prednisolone Acetate Injection....................................................................	Intra-articular use
Prednisolone Methyl Acetate Injections....................................................................
Prednisolone Tertiary Butyl Acetate Injections
Prednisolone Trimethylacetate Injections
Methylprednisolone Tablets, B.P....................................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Methylprednisolone Capsules....................................................................
Prednisolone Sodium Hemisuccinate					With the written authority of the Director-General, medical or surgical crises
Prednisone Tablets, B.P....................................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Habitual abortion
Progesterone....................................................................	Progesterone deficiency proven by hormonal assay of lateral wall smear
Protoveratrine A....................................................................	Hypertensive crises
Pyrazinamide....................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Pyridostigmine Injection, B.P----------------	Myasthenia gravis
Pyridostigmine Tablets, B.P........................
Pyridoxine Hydrochloride Tablets	Peripheral neuritis due to isoniazid therapy
Radiation sickness
Riboflavine Tablets.......................................	Any disease or condition in a pensioner
Senna Fruit Extract (Standardised)
Sobee...............................................................	With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy in children under the age of four years
Sodium Aminosalicylate Tablets. B.P.	Tuberculosis
Sodium Aminosalicylate Injection
Sodium Aminosalicylate Cachets
Sodium Aminosalicylate Granules
Sodium Folate................................................	Macrocytic anaemia
Sprue or the sprue-like syndrome
Spiramycin......................................................	A disease or condition specified in this column in relation to Erythromycin
Spironolactone Tablets, B.P.........................	With the written authority of the Director-General, to supplement other diuretics when these have proved inadequate.
Stanolone........................................................	Mammary carcinoma
With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis
Stanozolol.......................................................	With the written authority of the Director-General, intermittent use for steroid-induced osteoporosis
Stilboestrol Injection....................................	Carcinoma of the prostate
Stilboestrol Tablets, B.P...............................	Mammary carcinoma
Any disease or condition in a pensioner
Streptomycin Sulphate Injections...............	Bacillary dysentery that is resistant to the Sulphonamides
Brucellosis
Chancroid
Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Friedlander bacillus infections
Haemophilus influenzae infections
Plague
Pseudomonas pyocyanea infections
Rat-bite fever (Streptobacillus moniliformis)
Salmonella infections
Surgical conditions of the bowel (pre-operative and post-operative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections that are resistant to the Sulphonamides
Sulphasalazine...............................................	Ulcerative colitis
Sulphomyxin Sodium...................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Sultiame..........................................................	For use where other anticonvulsants have failed
Surgical Cement............................................	Ileostomy or colostomy conditions
Surgical Cement Solvent..............................

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Sustanon.........................................................................
Testosterone Implants, B.P.........................................................................
Testosterone Oenanthate.........................................................................	Castration syndrome (male and female)
Testosterone Propionate Injection, B.P.........................................................................	Klinefelter Reifenstein Albright syndrome
Methyltestosterone Tablets, B.P.........................................................................	Mammary carcinoma
Methyltestosterone, B.P.........................................................................
Tetanus Immune Globulin (Human)	With the written authority of the Director-General, where patients are known to be sensitive to horse serum and cattle scrum
Tetracycline Capsules, B.P.........................................................................	A disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
Tetracycline Tablets, B.P.........................................................................
Tetracycline Injections.........................................................................
Tetracycline Hydrochloride, with a buffering agent—Capsules and Injection.........................................................................
Rolitetracycline.........................................................................
Tetracycline Granules.........................................................................
Tetracycline Paediatric Drops.........................................................................
Tetracycline Oral Suspension.........................................................................
Tetracycline with a buffering agent—Paediatric Drops.........................................................................
Tetracycline with a buffering agent—Oral Suspension.........................................................................
Tetracycline with a buffering agent and Amphotericin B.........................................................................

Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules except herpes zoster ophthalmicus
		Tetracycline with a buffering agent and Nystatin.........................................................................
Thiambutosine Tablets, B.P.........................................................................	Hansen’s disease
Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
Thioridazine Tablets, B.P.........................................................................	With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
Thioridazine.........................................................................
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride, Imipramine Hydrochloride or Nortriptyline Hydrochloride
Thyrotrophin.........................................................................	Any disease in or condition in a patient receiving treatment in or at an approved hospital
Tragacanth (Gum Karaya).........................................................................	Ileostomy or colostomy conditions
Trasylol.........................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital

Fifth Schedule—continued

Pharmaceutical Benefits	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act
Tretamine...................................................................	Malignant lymphoma and related conditions
Triamcinolone...........................................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets
Trifluoperazine Tablets, B.P...................................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Late-stage malignancy
Radiation sickness
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine Hydrochloride, Thioridazine Hydrochloride, Amitriptyline Hydrochloride Imipramine Hydrochloride or Nortriptyline Hydrochloride
Trimetaphan Injection, B.P.....................................	Hypotensive for anaesthesia
Vadrine.......................................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vasopressin Nasal Spray.........................................	Diabetes insipidus
Velactin......................................................................	With the written authority of the Director-General—
Galactosaemia
Lactose intolerance
Milk allergy in children under the age of four years
Vinblastine Sulphate................................................	Hodgkin’s disease
Vincristine Sulphate................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Viomycin Sulphate..................................................
Viomycin Sulphate Injection, B.P.	Tuberculosis
Viomycin Sulphate with Viomycin Pantothenate
Vitamin A with Aneurine Hydrochloride, Riboflavine, Nicotinamide, Ascorbic Acid and Vitamin D	Any disease or condition in a pensioner

        

_______________________

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra